Navigation Links
New hope for advanced post-menopausal breast cancer patients resistant to hormonal therapy
Date:9/25/2011

Stockholm, Sweden: Results from a phase III clinical trial have shown that combining two existing cancer drugs to treat post-menopausal women with advanced breast cancer resistant to hormonal therapy significantly improves outcome. Researchers told the 2011 European Multidisciplinary Cancer Congress [1] that women treated with a combination of everolimus and exemestane had an improved progression-free survival of nearly seven months compared to women who were treated only with exemestane.

Trial leader, Professor Jos Baselga from the Massachusetts General Hospital and Harvard Medical School, Boston (USA), will tell the meeting: "These results are impressive and, potentially, could represent a new therapeutic option for women with advanced post-menopausal breast cancer who have previously been treated with hormonal therapy."

The hormone oestrogen promotes the growth of about two thirds of breast cancers, and hormonal therapies such as exemestane, which block the effect of oestrogen or reduce oestrogen levels, are used to treat these hormone receptor-positive breast cancers. However, many breast cancer patients and nearly all patients with advanced breast cancer that has spread (metastasised) to other parts of the body become resistant to hormonal therapy. "When patients stop responding to hormonal therapy, the benefits from any secondary therapy are limited," says Prof. Baselga.

Exemestane is currently used to treat women who have metastatic breast cancer and women whose breast cancer has returned after initial treatment. It is also used to treat women with early breast cancer after they have completed two or three years of treatment with another hormonal therapy, tamoxifen.

Everolimus is an established treatment for recurrent, advanced kidney cancer and researchers are now looking at its use in other cancers. Phase II trials involving patients with advanced cancer driven by oestrogen receptor-positive advanced breast cancer h
'/>"/>

Contact: Saffina Rana
saffina.rana@europe.com
ECCO-the European CanCer Organisation
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S.
2. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
3. Split-course palliative radiotherapy confirmed as effective treatment for advanced NSCLC
4. Drug for advanced kidney cancer shrinks tumors prior to surgery
5. Siemens Awards for Advanced Placement Honor Top U.S. Science and Math Students and Teachers
6. Family members reduce stress in advanced cancer patients with 14 minute massages
7. Accelerated radiation therapy reduces toxicity in patients with advanced head and neck cancers
8. Proton beam therapy shows encouraging long-term outcome for patients with locally advanced sinonasal cancers
9. Castrate-Metastatic Prostate Cancer: Therapeutic Considerations for Advanced Disease
10. AdvancedMD Appoints William Stone Vice President and General Manager of Billing Services Partner Program
11. BOTOX Cosmetic & Wrinkle Filler Specialist Hosts Advanced Training Event at Ageless Beauty in Mountain Home, ID
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... York, NY (PRWEB) May 24, 2013 ... Yahoo Commerce VP, Brandon Huff as Executive Vice President ... its commerce business units, which represented a large portion ... lead digital growth as Dwell develops a fully-integrated commerce ... a decade of experience monetizing digital content for leading ...
(Date:5/24/2013)... 6Webs.com has educated thousands of buyers ... home security monitoring provider. The easy to read ... resource consumers prefer for unbiased and impartial home security ... the leading wireless home security system providers in the ... a number of key factors including reliability, technology and ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Based ... is a leading nationwide sales, installation and service ... consumer and commercial applications. The company’s core products ... vehicle lifts for mobility devices, pool lifts, turning ... Mobility operates over 30 locations, primarily through its ...
(Date:5/24/2013)... 23 May 2013, Paris, France: Routinely measuring fractional ... coronary angiography for diagnosis of chest pain leads ... in four patients, according to results from a ... (Does routine pressure wire assessment influence management strategy ... study was designed to assess whether routine assessment ...
(Date:5/24/2013)... May 24, 2013 In a coup that ... Greg DeLange of the Estetica Institute of the Palm ... KOOL 105.5 FM’s popular morning show, “The Mo & Sally ... experiences and their satisfaction with the results, giving Dr. DeLange ... located in Palm Beach Gardens, very valuable free publicity. , ...
Breaking Medicine News(10 mins):Health News:Yahoo Commerce Head Joins Leadership at Dwell Media 2Health News:2013 Best Wireless Security System Providers Reported by 6Webs.com 2Health News:Cortec Closes Equity Transaction with 101 Mobility 2Health News:Diagnostic coronary angiography: Functional flow reserve changes decisions in 25 percent of cases 2Health News:Dr. Greg DeLange of the Estetica Institute Recently Performed Eye Surgery on Both Members of Popular Morning Radio Team 2
... March 18 Askesis Development Group, Inc., a ... addictions treatment, and social services markets, is pleased ... and enhanced features are focused on creating a ... a comprehensive electronic medical record (EMR), and streamlined ...
... of certain cytokines spiked during disease stage , , WEDNESDAY, ... recently had the rare opportunity to follow the West ... in a 29-year-old lab worker who had accidentally jabbed ... researchers followed the trajectory of cytokines, a type of ...
... Institute of Technology are opening a new center that ... resonance imaging scanner to further study into the mysteries ... Advanced Brain Imaging, a joint venture of Georgia State ... topics from autism and learning disabilities, to applied physiology, ...
... disease recurrence, death nearly twice that of normal-weight patients ... cancer patients are more likely than non-obese patients to ... say U.S. researchers. , "We identified a subset ... at 12-fold increased risk of lymph node metastasis compared ...
... CEO until Executive Search for Replacement is CompletedPlanned ... 2009 at 4:15 PM ET LIVINGSTON, N.J., ... Board: MLSS), the recognized leader in advanced injection ... the Board, will temporarily assume the post of ...
... 18 The American Academy of Nurse Practitioners (AANP) ... position of AANP Chief Executive Officer, effective March 20, ... FAANP, who will retire after 13 years as CEO ... will continue in her role as Executive Director of ...
Cached Medicine News:Health News:Askesis Development Group, Inc. Launches New Behavioral Health Software for Electronic Medical Records (EMR) and Practice Management 2Health News:Course of West Nile Infection Charted 2Health News:Course of West Nile Infection Charted 3Health News:Georgia State/Georgia Tech Center for Advanced Brain Imaging to expand brain, mind research 2Health News:Obesity Tied to Poor Pancreatic Cancer Surgery Outcomes 2Health News:Milestone Scientific Announces Resignation of CEO 2Health News:Milestone Scientific Announces Resignation of CEO 3Health News:American Academy of Nurse Practitioners Announces New Chief Executive Officer 2
(Date:5/23/2013)... 23, 2013 Amgen (NASDAQ: AMGN ) ... Healthcare Conference on Thursday, May 30, 2013, at the Westin ... 9:20 a.m. Eastern Daylight Time. Arvind Sood ... at the conference. Live audio of the presentation can be ... , under Investors. A replay of the webcast will also ...
(Date:5/23/2013)... 23, 2013  A recently published clinical study conducted ... Texas , demonstrates that 3D mammography (breast tomosynthesis) ... The study, "Implementation of Breast Tomosynthesis ... led by Stephen L. Rose , ... American Journal of Roentgenology (AJR). The AJR ...
(Date:5/23/2013)... 23, 2013 Anthem Blue Cross patients with ... required them to obtain their medications by mail order ... Whatley Kallas LLC.  The lawsuit, filed ... Blue Cross,s mandatory mail order program announced late last ... privacy. "This settlement brings to a close ...
Breaking Medicine Technology:First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3
... Smith & Nephew Orthopaedics (NYSE: SNN ) ... French biotechnology company Graftys. The deal gives Smith & ... bone void filler in the U.S., and potentially in ... committed to offering our surgeon customers innovative solutions which ...
... 24, 2011 HealthWarehouse.com, Inc. (OTC: HEWA) a leading ... results for the first quarter ended March 31, 2011. ... the Company,s quarterly net sales increased $1,031,003 to $2,284,552, ... This growth was driven by strength in its prescription ...
Cached Medicine Technology:Smith & Nephew Signs Distribution Agreement for Unique Injectable Bone Void Filler With Graftys 2Smith & Nephew Signs Distribution Agreement for Unique Injectable Bone Void Filler With Graftys 3HealthWarehouse.com Reports 82% Quarter-Over-Quarter Revenue Growth in the First Quarter 2011 2
The Skull Pins are inserted into the receptacles of the Skull Clamp and fixate the head during surgery....
It is designed for rigid skeletal fixation. These pins are constructed of stainless steel and can be removed for sterilization and reuse....
Mayfield radiolucent skull clamp....
... for general applications and are equipped with our ... i.e. rigid endoscopes, range between 1 mm and ... to a 120 retrospection, and image angles ranging ... Endoscopes with working lengths of 1.5 meters and ...
Medicine Products: